↓ Skip to main content

Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm

Overview of attention for article published in Frontiers in endocrinology, June 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm
Published in
Frontiers in endocrinology, June 2022
DOI 10.3389/fendo.2022.882381
Pubmed ID
Authors

Francesco Calvanese, Timothée Jacquesson, Romain Manet, Alexandre Vasiljevic, Hélène Lasolle, Francois Ducray, Gerald Raverot, Emmanuel Jouanneau

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 2 13%
Student > Master 2 13%
Student > Postgraduate 1 7%
Student > Bachelor 1 7%
Unknown 9 60%
Readers by discipline Count As %
Medicine and Dentistry 3 20%
Biochemistry, Genetics and Molecular Biology 1 7%
Neuroscience 1 7%
Chemistry 1 7%
Unknown 9 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2022.
All research outputs
#7,397,481
of 26,169,168 outputs
Outputs from Frontiers in endocrinology
#2,113
of 13,372 outputs
Outputs of similar age
#136,257
of 452,367 outputs
Outputs of similar age from Frontiers in endocrinology
#119
of 920 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 13,372 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 920 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.